Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Friedman, Lee
and
Wiechers, Ilse R
1996.
The brain hallucinates and gets caught in the web.
The Lancet,
Vol. 348,
Issue. ,
p.
S21.
Nilsson, Agneta
Waller, Lotte
Rosengren, Annika
Adlerberth, Annika
and
Wilhelmsen, Lars
1997.
Cigarette smoking is associated with abnormal involuntary movements in the general male population—a study of men born in 1933.
Biological Psychiatry,
Vol. 41,
Issue. 6,
p.
717.
McCreadie, R. G.
Latha, S.
Thara, R.
Padmavathi, R.
and
Ayankaran, J. R.
1997.
Poor memory, negative symptoms and abnormal movements in never-treated Indian patients with schizophrenia.
British Journal of Psychiatry,
Vol. 171,
Issue. 4,
p.
360.
Schröder, Johannes
Silvestri, Simone
Bubeck, Bernd
Karr, Markus
Demisch, Sibylle
Scherrer, Sabine
Geider, Franz J
and
Sauer, Heinrich
1998.
D2 Dopamine Receptor Up-Regulation, Treatment Response, Neurological Soft Signs, and Extrapyramidal Side Effects in Schizophrenia: A Follow-Up Study with 123I-Iodobenzamide Single Photon Emission Computed Tomography in the Drug-Naive State and after Neuroleptic Treatment.
Biological Psychiatry,
Vol. 43,
Issue. 9,
p.
660.
King, David J.
and
Wager, Elizabeth
1998.
Haematological safety of antipsychotic drugs.
Journal of Psychopharmacology,
Vol. 12,
Issue. 3,
p.
283.
Beveridge, Allan
1999.
Relevance of the history of psychiatry to practising clinicians.
Advances in Psychiatric Treatment,
Vol. 5,
Issue. 1,
p.
46.
Lieberman, Jeffrey A
1999.
Is schizophrenia a neurodegenerative disorder? a clinical and neurobiological perspective.
Biological Psychiatry,
Vol. 46,
Issue. 6,
p.
729.
Hietala, Jarmo
Syvälahti, Erkka
Vilkman, Harry
Vuorio, Klaus
Räkköläinen, Viljo
Bergman, Jörgen
Haaparanta, Merja
Solin, Olof
Kuoppamäki, Mikko
Eronen, Esa
Ruotsalainen, Ulla
and
Salokangas, Raimo K.R.
1999.
Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia.
Schizophrenia Research,
Vol. 35,
Issue. 1,
p.
41.
Eich, Ph.
1999.
Leponex.
p.
29.
Thara, R.
and
McCreadie, R. G.
1999.
Research in India: success through collaboration.
Advances in Psychiatric Treatment,
Vol. 5,
Issue. 3,
p.
221.
Court, J.A
Piggott, M.A
Lloyd, S
Cookson, N
Ballard, C.G
McKeith, I.G
Perry, R.H
and
Perry, E.K
2000.
Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson’s disease and Alzheimer’s disease and in relation to neuroleptic medication.
Neuroscience,
Vol. 98,
Issue. 1,
p.
79.
van Ss, J.
Walsh, E.
van Horn, E.
Tattan, T.
Bale, R.
and
Thompson, S. G.
2000.
Changes in negative symptoms and the risk of tardive dyskinesia: a longitudinal study.
Acta Psychiatrica Scandinavica,
Vol. 101,
Issue. 4,
p.
300.
Krüger, Stephanie
Bräunig, Peter
Höffler, Jürgen
Shugar, Gerald
Börner, Ingrid
and
Langkrär, Julia
2000.
Prevalence of Obsessive-Compulsive Disorder in Schizophrenia and Significance of Motor Symptoms.
The Journal of Neuropsychiatry and Clinical Neurosciences,
Vol. 12,
Issue. 1,
p.
16.
Gervin, Maurice
and
Barnes, Thomas R.E.
2000.
Assessment of drug-related movement disorders in schizophrenia.
Advances in Psychiatric Treatment,
Vol. 6,
Issue. 5,
p.
332.
Ss, J.
Walsh, E.
Horn, E.
Tattan, T.
Bale, R.
and
Thompson, S. G.
2000.
Changes in negative symptoms and the risk of tardive dyskinesia: a longitudinal study.
Acta Psychiatrica Scandinavica,
Vol. 101,
Issue. 4,
p.
300.
Srinivasan, T.N.
Thara, R.
Padmavathi, R.
and
McCreadie, R.G.
2001.
Relationship of extrapyramidal symptoms to age at onset and drug treatment in middle-aged and elderly schizophrenic patients.
Schizophrenia Research,
Vol. 47,
Issue. 1,
p.
69.
Løvlie, R
Thara, R
Padmavathi, R
Steen, V M
and
McCreadie, R G
2001.
Ser9Gly dopamine D3 receptor polymorphism and spontaneous dyskinesia in never-medicated schizophrenic patients.
Molecular Psychiatry,
Vol. 6,
Issue. 1,
p.
6.
Quinn, John
Meagher, David
Murphy, Patrice
Kinsella, Anthony
Mullaney, James
and
Waddington, John L.
2001.
Vulnerability to involuntary movements over a lifetime trajectory of schizophrenia approaches 100%, in association with executive (frontal) dysfunction.
Schizophrenia Research,
Vol. 49,
Issue. 1-2,
p.
79.
Church, S. M.
Cotter, D.
Bramon, E.
and
Murray, R. M.
2002.
Stroke-Vascular Diseases.
p.
129.
McAllister-Williams, R. Hamish
and
Ferrier, I. Nicol
2002.
Rapid tranquillisation: Time for a reappraisal of options for parenteral therapy.
British Journal of Psychiatry,
Vol. 180,
Issue. 06,
p.
485.
eLetters
No eLetters have been published for this article.